NEURO2026

*Shambhavi Chaturvedi^1,2, Haruka Yamamoto², Akihiro Matsumoto², Manabu Abe³, Toshikuni Sasaoka⁴, Keisuke Yonehara^1,2,5 (1. Graduate University for Advanced Studies, SOKENDAI, 2. Multiscale Sensory Structure Laboratory, National Institute of Genetics, Mishima, Shizuoka, Japan, 3. Department of Animal Model Development, Brain Research Institute, Niigata University, Niigata, Japan, 4. Department of Comparative and Experimental Medicine, Brain Research Institute, Niigata University, Niigata, Japan, 5. Danish Research Institute of Translational Neuroscience–Nordic-EMBL Partnership for Molecular Medicine, Department of Biomedicine, Aarhus University, Aarhus C, Denmark)

*Takuya Yamane^1,2, Sosuke Yoneda², Erika Kasai², Toshiaki Kume³, Daisuke Uta³ (1. Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2. Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., 3. Department of Applied Pharmacology, Faculty of Pharmaceutical Sciences, University of Toyama)

*Kotaro Muramatsu^1,2,3, Kazutaka Maeda³, Yuta Soga^3,4, Shiro Egawa³, Enrique Contreras-Hernandez³, Trevor Shawn Smith³, Taku Hasegawa³, Akito Kosugi³, Shusei Fukuyama⁵, Mirai Takahashi⁵, Kaoru Takakusaki⁵, Kazuhiko Seki³ (1. Univ of Copenhagen, Copenhagen, Denmark, 2. Univ of Tokyo, 3. National Center of Neurology and Psychiatry, 4. Univ of Electro-Communications, 5. Asahikawa Med Univ)

*Aleksandra Gavrilova¹, Bernd Kuhn¹ (1. Okinawa Institute of Science and Technology)